Nikhil Prasad Fact checked by:Thailand Medical News Team Jan 05, 2025 1 day, 19 hours, 9 minutes ago
Medical News: A New Insight into Human Metapneumovirus Immune Evasion
Scientists from the University of Pittsburgh School of Medicine-USA have made a significant discovery about the mechanisms behind the human metapneumovirus (HMPV), a virus that causes severe respiratory infections. Led by Adam Brynes, Yu Zhang, and John V. Williams from the Department of Pediatrics and the Program in Microbiology and Immunology, their research uncovers how HMPV employs its small hydrophobic (SH) protein to impair the host’s immune system by promoting the degradation of JAK1, a key protein in immune signaling.
JAK1 Degradation by HMPV SH Protein Impairs Host IL-6 Signaling
This
Medical News report delves into the detailed findings of the study, shedding light on how the SH protein disrupts IL-6 and interferon (IFN) signaling. This disruption weakens the body’s ability to fight the virus, providing new avenues for therapeutic interventions against respiratory infections.
The Role of HMPV in Respiratory Illnesses
HMPV is a leading cause of respiratory infections, particularly in children, the elderly, and individuals with underlying health conditions. Despite its global prevalence, there are currently no approved treatments or vaccines available for HMPV infections. The virus’s success as a pathogen largely stems from its ability to evade the host’s immune defenses. This study highlights one of the critical mechanisms by which HMPV achieves this: targeting the host’s immune signaling pathways.
The researchers focused on the SH protein of HMPV, which is known to inhibit immune responses, particularly those involving type I and type II interferons. However, its role in disrupting IL-6 signaling was not well understood until now. IL-6 is a crucial cytokine in immune response, and its signaling relies on proteins like JAK1. The study revealed that the SH protein depletes JAK1 levels through proteasomal degradation, effectively sabotaging the host’s immune response.
Key Findings of the Study
The study utilized a combination of molecular biology techniques, including transfection experiments and the use of recombinant viruses, to explore the role of the SH protein in immune evasion. Key findings include:
-JAK1 Degradation: Cells infected with wild-type HMPV showed a significant reduction in JAK1 protein levels compared to those infected with an SH-deleted mutant (ΔSH). This indicates that the SH protein is essential for the degradation of JAK1.
-Proteasomal Pathway Involvement: The use of proteasome inhibitors partially restored JAK1 levels in infected cells, suggesting that the degradation is mediated by the proteasomal pathway.
-Direct Interaction Between SH and JAK1: Co-immunoprecipitation experiments confirmed that the SH protein interacts directly with JAK1 and ubiquitin, linking SH to the ubiquitin-proteasome system.
&nbs
p;
-Impact on IL-6 Signaling: Wild-type HMPV infection, but not ΔSH infection, significantly reduced IL-6-mediated STAT3 activation. This underscores the necessity of the SH protein in disrupting IL-6 signaling.
-Relocation of JAK1 to Viral Replication Factories: Confocal microscopy revealed that JAK1 is relocalized to viral inclusion bodies in infected cells, a phenomenon not observed in uninfected cells. This sequestration likely contributes to its degradation.
Implications for Treatment and Vaccines
The findings of this study have profound implications for the development of therapies against HMPV. By identifying the SH protein as a critical factor in immune evasion, researchers can focus on targeting this protein to restore the host’s immune responses. For instance, small molecules or antibodies that inhibit the interaction between SH and JAK1 could potentially prevent the degradation of JAK1, thereby preserving the immune signaling pathways.
Furthermore, the study’s insights into the SH protein’s role in disrupting IFN and IL-6 signaling provide a broader understanding of how HMPV undermines host defenses. This knowledge could pave the way for the development of vaccines that elicit immune responses capable of countering the virus’s evasion strategies.
Conclusions
The study concludes that the SH protein of HMPV is both necessary and sufficient to impair IL-6 and IFN signaling by promoting the proteasomal degradation of JAK1. By interacting with JAK1 and components of the ubiquitin-proteasome system, the SH protein effectively neutralizes a critical component of the host’s immune defense. These findings enhance our understanding of the immune evasion mechanisms employed by HMPV, a pathogen of significant public health concern.
Understanding these mechanisms is crucial not only for combating HMPV but also for addressing related viruses that employ similar strategies to evade the immune system. This study represents a significant step forward in the fight against respiratory infections caused by HMPV and similar pathogens.
The study findings were published on a preprint server.
https://www.biorxiv.org/content/10.1101/2024.05.10.593594v1
For the latest HMPV News, keep on logging to Thailand
Medical News.
Read Also:
https://www.thailandmedical.news/news/human-metapneumovirus-small-hydrophobic-protein-has-viporin-like-properties-and-modulates-viral-fusogenic-activity
https://www.thailandmedical.news/news/australian-drug-repurposing-study-uncovers-potential-inhibitors-against-human-metapneumovirus
https://www.thailandmedical.news/news/chlorpromazine-found-to-inhibit-human-metapneumovirus-hmpv-by-blocking-virus-internalization
https://www.thailandmedical.news/articles/hmpv-human-metapneumovirus
Share
Tweet
Share
